Nicotinic acetylcholine receptors: Conventional and unconventional ligands and signaling.


Journal

Neuropharmacology
ISSN: 1873-7064
Titre abrégé: Neuropharmacology
Pays: England
ID NLM: 0236217

Informations de publication

Date de publication:
15 05 2020
Historique:
received: 24 12 2019
revised: 05 02 2020
accepted: 25 02 2020
pubmed: 9 3 2020
medline: 28 5 2021
entrez: 9 3 2020
Statut: ppublish

Résumé

Postsynaptic nAChRs in the peripheral nervous system are critical for neuromuscular and autonomic neurotransmission. Pre- and peri-synaptic nAChRs in the brain modulate neurotransmission and are responsible for the addictive effects of nicotine. Subtypes of nAChRs in lymphocytes and non-synaptic locations may modulate inflammation and other cellular functions. All AChRs that function as ligand-gated ion channels are formed from five homologous subunits organized to form a central cation channel whose opening is regulated by ACh bound at extracellular subunit interfaces. nAChR subtype subunit composition can range from α7 homomers to α4β2α6β2β3 heteromers. Subtypes differ in affinities for ACh and other agonists like nicotine and in efficiencies with which their channels are opened and desensitized. Subtypes also differ in affinities for antagonists and for positive and negative allosteric modulators. Some agonists are "silent" with respect to channel opening, and AChRs may be able to signal metabotropic pathways by releasing G-proteins independent of channel opening. Electrophysiological studies that can resolve single-channel openings and molecular genetic approaches have allowed characterization of the structures of ligand binding sites, the cation channel, and the linkages between them, as well as the organization of AChR subunits and their contributions to function. Crystallography and cryo-electron-microscopy are providing increasing insights into the structures and functions of AChRs. However, much remains to be learned about both AChR structure and function, the in vivo functional roles of some AChR subtypes, and the development of better pharmacological tools directed at AChRs to treat addiction, pain, inflammation, and other medically important issues. This article is part of the special issue on 'Contemporary Advances in Nicotine Neuropharmacology'.

Identifiants

pubmed: 32146229
pii: S0028-3908(20)30087-3
doi: 10.1016/j.neuropharm.2020.108021
pmc: PMC7610230
mid: NIHMS1575534
pii:
doi:

Substances chimiques

Ligands 0
Nicotinic Agonists 0
Nicotinic Antagonists 0
Receptors, Nicotinic 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

108021

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM057481
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Références

Neuron. 1988 Mar;1(1):45-54
pubmed: 3272154
Brain Res. 2002 Sep 6;948(1-2):33-46
pubmed: 12383953
J Biol Chem. 2014 Feb 14;289(7):4515-31
pubmed: 24362025
J Biol Chem. 2016 Nov 4;291(45):23452-23463
pubmed: 27645992
J Physiol. 1998 Jun 15;509 ( Pt 3):651-65
pubmed: 9596789
Prog Brain Res. 1990;86:195-203
pubmed: 2087557
Alcohol. 2001 Jun;24(2):63-8
pubmed: 11522424
J Intern Med. 2009 Jun;265(6):663-79
pubmed: 19493060
Life Sci. 2007 May 30;80(24-25):2286-9
pubmed: 17331545
Trends Pharmacol Sci. 2004 Jun;25(6):317-24
pubmed: 15165747
Harvey Lect. 1979-1980;75:85-254
pubmed: 400609
Eur J Neurosci. 1997 Jun;9(6):1201-11
pubmed: 9215704
J Pharmacol Exp Ther. 2009 Nov;331(2):547-54
pubmed: 19644040
Mol Pharmacol. 2011 Dec;80(6):1013-32
pubmed: 21885620
Neuron. 2019 Nov 6;104(3):431-432
pubmed: 31697916
J Neurosci. 2003 Aug 27;23(21):7820-9
pubmed: 12944511
Eur J Pharmacol. 2000 Mar 30;393(1-3):179-95
pubmed: 10771012
J Pharmacol Exp Ther. 1998 Jul;286(1):311-20
pubmed: 9655874
Mol Pharmacol. 2006 Aug;70(2):755-68
pubmed: 16720757
Clin Pharmacol Ther. 1990 Mar;47(3):323-30
pubmed: 2178852
Trends Pharmacol Sci. 2015 Aug;36(8):514-23
pubmed: 26067101
Science. 1988 Apr 15;240(4850):330-4
pubmed: 2832952
Mol Pharmacol. 2012 May;81(5):710-8
pubmed: 22328718
J Biol Chem. 2016 Jan 29;291(5):2444-59
pubmed: 26644472
Drug Alcohol Depend. 2008 Jan 1;92(1-3):3-8
pubmed: 17825502
Am J Physiol Cell Physiol. 2009 Nov;297(5):C1294-306
pubmed: 19741199
Mol Med. 2009 Jul-Aug;15(7-8):195-202
pubmed: 19593403
Nature. 2011 Mar 31;471(7340):597-601
pubmed: 21278726
Nucleic Acids Res. 1990 Nov 25;18(22):6714
pubmed: 2251144
Nat Neurosci. 2011 Sep 11;14(10):1253-9
pubmed: 21909087
J Neurosci. 2008 Nov 19;28(47):12318-27
pubmed: 19020025
J Physiol Paris. 2012 Jan;106(1-2):47-56
pubmed: 21762779
J Neurosci. 2005 Nov 23;25(47):10905-12
pubmed: 16306403
Neuropharmacology. 2014 Jan;76 Pt B:545-53
pubmed: 23632083
J Neurochem. 2014 Apr;129(2):315-27
pubmed: 24266758
Biochemistry. 1990 Dec 18;29(50):11009-23
pubmed: 1703009
J Comp Neurol. 1946 Apr;84:141-219
pubmed: 20982804
Eur J Pharmacol. 2014 Mar 15;727:181-5
pubmed: 24530419
Toxicon. 2016 Sep 1;119:8-20
pubmed: 27163885
Neuron. 1992 Feb;8(2):353-62
pubmed: 1310863
Int J Mol Sci. 2019 Mar 08;20(5):
pubmed: 30857127
Neuron. 2019 Nov 6;104(3):501-511.e6
pubmed: 31488329
J Biol Chem. 2015 Feb 6;290(6):3552-62
pubmed: 25516597
Neuropharmacology. 2016 Aug;107:189-200
pubmed: 26926428
J Neurosci. 2010 Jul 21;30(29):9877-89
pubmed: 20660270
J Pharmacol Exp Ther. 1993 Jun;265(3):1455-73
pubmed: 8510022
J Am Chem Soc. 2017 Mar 15;139(10):3676-3684
pubmed: 28221788
Br J Pharmacol. 2006 Jan;147 Suppl 1:S277-86
pubmed: 16402115
J Natl Cancer Inst. 2010 Sep 8;102(17):1322-35
pubmed: 20733118
Am J Med Genet B Neuropsychiatr Genet. 2009 Oct 5;150B(7):926-33
pubmed: 19132693
J Pharmacol Exp Ther. 1998 Dec;287(3):918-25
pubmed: 9864273
J Physiol. 1996 Feb 15;491 ( Pt 1):151-61
pubmed: 9011607
Mol Pharmacol. 2003 Feb;63(2):311-24
pubmed: 12527802
J Neurosci. 2010 Apr 14;30(15):5311-25
pubmed: 20392953
PLoS One. 2016 Feb 29;11(2):e0150230
pubmed: 26925951
Br J Pharmacol. 2018 Jun;175(11):1805-1821
pubmed: 28199738
Trends Pharmacol Sci. 2018 Apr;39(4):354-366
pubmed: 29428175
Front Pharmacol. 2011 Dec 27;2:81
pubmed: 22207849
Nature. 2016 Oct 20;538(7625):411-415
pubmed: 27698419
Nat Immunol. 2005 Aug;6(8):844-51
pubmed: 16025117
Ann N Y Acad Sci. 2000;909:88-103
pubmed: 10911925
Prog Neurobiol. 1993 Oct;41(4):509-31
pubmed: 7692467
Biophys J. 1988 Jan;53(1):1-10
pubmed: 2449251
Trends Neurosci. 1996 Mar;19(3):96-101
pubmed: 9054063
Nature. 1991 Oct 31;353(6347):846-9
pubmed: 1719423
Neuroreport. 1997 Aug 18;8(12):2739-42
pubmed: 9295110
J Neurophysiol. 2002 Jan;87(1):548-57
pubmed: 11784770
Mol Pharmacol. 2003 Feb;63(2):419-28
pubmed: 12527814
Neuron. 1994 Jan;12(1):179-89
pubmed: 7507339
J Med Chem. 2005 May 19;48(10):3474-7
pubmed: 15887955
J Biol Chem. 1980 Nov 10;255(21):10144-56
pubmed: 7430118
Nicotine Tob Res. 2015 Mar;17(3):361-7
pubmed: 25180076
Psychopharmacology (Berl). 2006 Mar;184(3-4):523-39
pubmed: 16220335
J Neurosci. 2003 Dec 3;23(35):11045-53
pubmed: 14657161
J Neurosci. 2000 Jan 15;20(2):529-41
pubmed: 10632582
Trends Neurosci. 2004 Jun;27(6):329-36
pubmed: 15165737
J Comp Neurol. 1989 Jun 8;284(2):314-35
pubmed: 2754038
PLoS One. 2016 Mar 17;11(3):e0151934
pubmed: 26986966
J Gen Physiol. 2011 Apr;137(4):369-84
pubmed: 21444659
Front Cell Neurosci. 2017 Sep 22;11:287
pubmed: 29018331
Proc Natl Acad Sci U S A. 2011 Apr 5;108(14):5867-72
pubmed: 21436053
Biophys J. 1993 Jul;65(1):29-42
pubmed: 7690261
Cent Nerv Syst Agents Med Chem. 2017;17(2):90-99
pubmed: 27573666
J Physiol. 1988 Jan;395:131-59
pubmed: 2457675
Mol Pharmacol. 2003 Feb;63(2):332-41
pubmed: 12527804
Science. 2004 Nov 5;306(5698):1029-32
pubmed: 15528443
Mol Pharmacol. 2012 Oct;82(4):746-59
pubmed: 22828799
Mol Pharmacol. 2007 Sep;72(3):715-24
pubmed: 17565004
J Physiol. 1987 Apr;385:325-59
pubmed: 2443668
J Biol Chem. 2015 May 29;290(22):13907-18
pubmed: 25869137
Gastroenterology. 2006 May;130(6):1822-30
pubmed: 16697744
J Pharmacol Exp Ther. 2010 May;333(2):501-18
pubmed: 20100906
Pharmacol Biochem Behav. 2003 Jun;75(3):607-18
pubmed: 12895678
Behav Brain Res. 2017 Aug 30;333:251-257
pubmed: 28693859
Mol Pharmacol. 2005 Dec;68(6):1863-76
pubmed: 16186249
Genomics. 1992 Aug;13(4):962-7
pubmed: 1505988
J Neurosci. 2009 May 6;29(18):6022-32
pubmed: 19420269
J Physiol. 1986 Apr;373:129-62
pubmed: 2427693
Eur J Neurosci. 2003 Apr;17(7):1329-37
pubmed: 12713636
J Cell Biol. 1999 Jul 12;146(1):203-18
pubmed: 10402471
Histochem Cell Biol. 2002 Dec;118(6):441-7
pubmed: 12483309
Mol Pharmacol. 2017 Mar;91(3):250-262
pubmed: 28069778
Eur J Pharmacol. 2004 Oct 11;502(1-2):31-40
pubmed: 15464087
Biochem Pharmacol. 2007 Oct 15;74(8):1235-46
pubmed: 17825262
Proc Natl Acad Sci U S A. 1987 Jan;84(2):595-9
pubmed: 3467376
J Neurosci. 2014 Nov 12;34(46):15159-69
pubmed: 25392484
J Invest Dermatol. 2004 Nov;123(5):937-49
pubmed: 15482483
Br J Pharmacol. 2018 Jun;175(11):1838-1854
pubmed: 28477386
Neuropharmacology. 1998 Sep;37(9):1095-102
pubmed: 9833639
J Pharmacol Exp Ther. 2014 Sep;350(3):665-80
pubmed: 24990939
Proc R Soc Lond B Biol Sci. 1985 Sep 23;225(1240):329-55
pubmed: 2414779
J Neurochem. 2012 Sep;122(6):1137-44
pubmed: 22774872
J Leukoc Biol. 2009 Jul;86(1):1-3
pubmed: 19567410
Nature. 2001 May 17;411(6835):269-76
pubmed: 11357122
Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1261-5
pubmed: 1741378
Biochem Pharmacol. 2015 Oct 15;97(4):463-472
pubmed: 26232730
Life Sci. 2012 Nov 27;91(21-22):1027-32
pubmed: 22659391
Annu Rev Pharmacol Toxicol. 2000;40:431-58
pubmed: 10836143
J Neurosci. 1985 May;5(5):1307-15
pubmed: 3998824
J Biol Chem. 2015 Aug 14;290(33):20060-70
pubmed: 26088141
PLoS One. 2013 Dec 05;8(12):e82719
pubmed: 24349346
Mol Pharmacol. 2019 Jan;95(1):43-61
pubmed: 30348894
J Neurol Sci. 2005 Feb 15;228(2):167-77
pubmed: 15694199
Neuropsychopharmacology. 2008 Aug;33(9):2158-66
pubmed: 18033235
Neuropharmacology. 2009 Jan;56(1):237-46
pubmed: 18723036
J Biol Chem. 1990 Mar 15;265(8):4472-82
pubmed: 1689727
Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006103
pubmed: 17253581
Mol Pharmacol. 2019 Jun;95(6):606-614
pubmed: 30944209
Trends Pharmacol Sci. 2010 Dec;31(12):580-6
pubmed: 20965579
Br J Pharmacol. 2009 Nov;158(6):1486-94
pubmed: 19845675
Nature. 1988 Sep 1;335(6185):66-8
pubmed: 3412460
J Neurosci. 2003 Oct 8;23(27):9004-15
pubmed: 14534234
Life Sci. 2004 Dec 3;76(3):263-80
pubmed: 15531379
J Pharmacol Exp Ther. 2009 Jul;330(1):40-53
pubmed: 19339660
Mol Neurobiol. 2002 Feb;25(1):79-112
pubmed: 11890459
Neuropharmacology. 2000 Oct;39(13):2570-90
pubmed: 11044728
Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14686-91
pubmed: 18791069
Neuron. 2016 Oct 19;92(2):316-329
pubmed: 27764665
Nature. 1986 May 22-28;321(6068):406-11
pubmed: 2423878
J Physiol. 1991;440:95-112
pubmed: 1725184
Brain Res. 1999 Jun 5;830(2):218-25
pubmed: 10366678
J Neurosci. 1991 Mar;11(3):837-45
pubmed: 1705971
Br J Pharmacol. 2015 Apr;172(7):1834-45
pubmed: 25440006
J Neurochem. 2002 May;81(3):606-14
pubmed: 12065669
Br J Pharmacol. 2018 Jun;175(11):1957-1972
pubmed: 28726253
Neurosci Lett. 1996 Aug 9;213(3):201-4
pubmed: 8873149
Neuropharmacology. 2002 Sep;43(3):374-84
pubmed: 12243767
Front Cell Neurosci. 2017 Jul 05;11:189
pubmed: 28725182
J Neuroimmunol. 2012 Oct 15;251(1-2):65-72
pubmed: 22884467
Proc Natl Acad Sci U S A. 1987 Nov;84(21):7763-7
pubmed: 2444984
J Biol Chem. 2018 Feb 16;293(7):2534-2545
pubmed: 29237730
J Physiol. 1995 Apr 1;484 ( Pt 1):87-105
pubmed: 7541465
Brain Res. 1997 Sep 12;768(1-2):49-56
pubmed: 9369300
Br J Pharmacol. 2002 Sep;137(1):49-61
pubmed: 12183330
Mol Pharmacol. 2008 Nov;74(5):1407-16
pubmed: 18678621
Front Immunol. 2018 Jul 30;9:1604
pubmed: 30105015
Nucleic Acids Res. 2019 Jul 2;47(W1):W636-W641
pubmed: 30976793
Nature. 1985 Jun 6-12;315(6019):474-7
pubmed: 4000275
J Neurosci. 1983 Mar;3(3):644-57
pubmed: 6827314
J Physiol. 1978 Apr;277:153-76
pubmed: 306437
Cell. 1994 Nov 18;79(4):705-15
pubmed: 7954834
AAPS J. 2009 Mar;11(1):167-77
pubmed: 19280351
Curr Neuropharmacol. 2018;16(4):415-425
pubmed: 28820052
Behav Pharmacol. 1999 Nov;10(6-7):675-80
pubmed: 10780509
Neuropharmacology. 2014 Feb;77:193-9
pubmed: 24095990
J Biol Chem. 2005 Jan 14;280(2):1257-63
pubmed: 15504725
Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7669-73
pubmed: 1881908
Annu Rev Biophys Biomol Struct. 2003;32:311-34
pubmed: 12695308
Biochemistry. 1978 May 30;17(11):2035-8
pubmed: 667008
Nature. 1998 Jan 8;391(6663):173-7
pubmed: 9428762
Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20819-24
pubmed: 24297903
J Biol Chem. 2019 Aug 9;294(32):12132-12145
pubmed: 31221718
J Neurosci. 1998 Mar 1;18(5):1904-12
pubmed: 9465015
Proc Natl Acad Sci U S A. 1999 May 11;96(10):5746-51
pubmed: 10318955
Neurosci Lett. 2005 Apr 22;378(3):140-4
pubmed: 15781147
J Biol Chem. 1984 Oct 10;259(19):11662-5
pubmed: 6480577
J Mol Neurosci. 2010 Jan;40(1-2):77-86
pubmed: 19672724
Biochem Pharmacol. 2014 May 1;89(1):1-11
pubmed: 24486571
Eur J Pharmacol. 2017 Jul 15;807:1-11
pubmed: 28438647
Mol Pharmacol. 2007 Mar;71(3):769-76
pubmed: 17132685
Eur J Neurosci. 2000 Oct;12(10):3664-74
pubmed: 11029636
Mol Pharmacol. 1997 Feb;51(2):320-7
pubmed: 9203638
Am J Transl Res. 2017 Mar 15;9(3):971-985
pubmed: 28386326
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3501-6
pubmed: 11248107
Life Sci. 2007 May 30;80(24-25):2290-3
pubmed: 17291541
Neuron. 1989 Nov;3(5):589-96
pubmed: 2484342
Trends Neurosci. 1997 Feb;20(2):92-8
pubmed: 9023878
Brain Res. 2009 Feb 23;1256:1-7
pubmed: 19063868
J Biol Chem. 2016 Mar 4;291(10):5049-67
pubmed: 26742843
Neuron. 2011 May 12;70(3):522-35
pubmed: 21555077
Eur J Pharmacol. 2013 Nov 15;720(1-3):264-75
pubmed: 24161916
Brain Res. 1995 Mar 20;674(2):252-9
pubmed: 7796104
Mol Pharmacol. 1999 Jan;55(1):58-66
pubmed: 9882698
Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):4007-12
pubmed: 9520483
Bioessays. 2013 Dec;35(12):1025-34
pubmed: 24185813
Nature. 2003 Jan 23;421(6921):384-8
pubmed: 12508119
PLoS One. 2013 Nov 14;8(11):e79653
pubmed: 24244538
Eur J Neurosci. 1997 Dec;9(12):2734-42
pubmed: 9517478
J Neurochem. 2002 Oct;83(1):48-56
pubmed: 12358728
J Pharmacol Exp Ther. 2007 Oct;323(1):294-307
pubmed: 17625074
J Cell Biol. 1983 Jul;97(1):217-23
pubmed: 6408100
Mol Pharmacol. 2008 Dec;74(6):1496-511
pubmed: 18768388
Neurosci Lett. 1998 Nov 13;256(3):163-6
pubmed: 9855365
Neuropharmacology. 1996;35(11):1547-56
pubmed: 9025102
Neuron. 1990 Dec;5(6):847-56
pubmed: 1702646
Mol Pharmacol. 2008 Jul;74(1):132-43
pubmed: 18381563
Nature. 2009 Mar 26;458(7237):534-7
pubmed: 19252481
Expert Opin Emerg Drugs. 2006 Sep;11(3):429-44
pubmed: 16939383
PLoS One. 2015 Jan 24;10(1):e0116227
pubmed: 25617631
J Gen Physiol. 2005 Jul;126(1):23-39
pubmed: 15955875
Mol Pharmacol. 2013 Sep;84(3):459-75
pubmed: 23839567
J Pharmacol Exp Ther. 1996 Apr;277(1):432-44
pubmed: 8613952
J Physiol. 2008 Feb 15;586(4):1105-15
pubmed: 18096596
Neurosci Lett. 2018 Jun 11;677:6-13
pubmed: 29679680
Proc Natl Acad Sci U S A. 2015 May 12;112(19):E2543-52
pubmed: 25918415
J Neurosci. 2008 Jul 30;28(31):7808-19
pubmed: 18667613
J Mol Biol. 1965 May;12:88-118
pubmed: 14343300
Nature. 2008 Aug 7;454(7205):722-7
pubmed: 18633353
Neuropharmacology. 2015 Apr;91:34-42
pubmed: 25497451
Neuron. 2016 Mar 2;89(5):948-55
pubmed: 26875622
Mol Pharmacol. 2008 Jun;73(6):1838-43
pubmed: 18367540
Am J Psychiatry. 2008 Sep;165(9):1163-71
pubmed: 18519524
Neuron. 1989 Nov;3(5):597-607
pubmed: 2642012
J Pharmacol Exp Ther. 2009 May;329(2):791-807
pubmed: 19223664
Bioorg Med Chem. 2016 Jan 15;24(2):286-93
pubmed: 26707847
Cold Spring Harb Perspect Med. 2013 Jan 01;3(1):a012112
pubmed: 23143843
Mol Pharmacol. 1995 Jan;47(1):164-71
pubmed: 7838125
Neuron. 1989 Oct;3(4):487-96
pubmed: 2642007
Eur J Pharmacol. 2006 Jun 6;539(1-2):10-7
pubmed: 16674940
Behav Brain Res. 2000 Aug;113(1-2):169-81
pubmed: 10942043
J Biol Chem. 2003 Sep 5;278(36):34411-7
pubmed: 12821669
Genome Biol. 2005;6(1):R4
pubmed: 15642096
J Pharmacol Exp Ther. 2019 Aug;370(2):252-268
pubmed: 31175218
Proc Natl Acad Sci U S A. 1981 Nov;78(11):7200-4
pubmed: 6947281
Eur J Neurosci. 2010 Mar;31(6):978-93
pubmed: 20377613
Crit Care Med. 2007 Apr;35(4):1139-44
pubmed: 17334244
FEBS Open Bio. 2017 Aug 07;7(9):1350-1361
pubmed: 28904864
ACS Med Chem Lett. 2017 Sep 26;8(10):989-991
pubmed: 29057037
J Neurosci. 1993 Feb;13(2):596-604
pubmed: 7678857
J Clin Psychiatry. 2009 Jul;70(7):1026-31
pubmed: 19323966
Biochem Pharmacol. 2009 Oct 1;78(7):703-11
pubmed: 19481063
Eur J Pharmacol. 2000 Mar 30;393(1-3):51-8
pubmed: 10770997
J Proteome Res. 2009 Apr;8(4):1849-58
pubmed: 19714875
Nature. 2018 May;557(7704):261-265
pubmed: 29720657
Biochem Pharmacol. 2011 Oct 15;82(8):915-30
pubmed: 21575610
Neuroreport. 1998 Sep 14;9(13):3097-101
pubmed: 9804323
Nature. 2000 May 25;405(6785):458-62
pubmed: 10839541
J Biol Chem. 1981 Aug 25;256(16):8294-7
pubmed: 7263653
Mol Pharmacol. 2018 Jun;93(6):601-611
pubmed: 29588343
J Biol Chem. 1996 Jul 26;271(30):17656-65
pubmed: 8663494

Auteurs

Roger L Papke (RL)

Department of Pharmacology and Therapeutics, University of Florida, P.O. Box 100267, Gainesville, FL, 32610-0267, USA. Electronic address: rlpapke@ufl.edu.

Jon M Lindstrom (JM)

Department of Neuroscience, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH